Androgen receptor expression in metastatic adenocarcinoma in females favors a breast primary

Diagnostic Pathology

Volumn 1, Issue 1, 2006, Pages

  Shidham, Vinod B ^a   Komorowski, Richard A ^a   Machhi, Jinobya K ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 34248210576     PISSN: None     EISSN: 17461596     Source Type: Journal    
DOI: 10.1186/1746-1596-1-34     Document Type: Article

References (30)

1. Wingo PA, Tong T, Bolden S: Cancer statistics 1995. CA Cancer J Clin 1995, 45:8-30.
2. Silverberg SG, DeLellis RA, Frable WJ: Principles and Practice of Surgical Pathology and Cytopathology. Churchill Livingston, New York; 1997.
3. Kaufmann O, Deidesheimer T, Muehlenberg M, Deicke P, Dietel M: Immunohistochemical differentiation of metastatic breast carcinomas from metastatic adenocarcinomas of other common primary sites. Histopathology 1996, 29(3):233-40.
4. Lee BH, Hecht JL, Pinkus JL, Pinkus GS: WTI, estrogen receptor, and progesterone receptor as markers for breast or ovarian primary site in metastatic adenocarcinoma to body fluids. Am J Clin Pothol 2002, 117(5):745-50.
5. Ormsby AH, SnowJL, Su WP, Goellner JR: Diagnostic immunohistochemistry of cutaneous metastatic breast carcinoma: a statistical analysis of the utility of gross cystic disease fluid protien-15 and estrogen receptor protein, J Am Acad Dermatol 1995, 32(5):711-6.
6. Longatto FA, Alves VA, Kanamura CT, Nonogaki S, Bortolan J, Lombardo V, Bisi H: Identification of the primary site of metastatic adenocarcinoma in serous effusions. Value of an immunocytochemical panel added to the clinical arsenal. Acta Cytol 2002, 46(4):651-8.
7. Wallace ML, Longacre TA, Smoller BR: Estrogen and progester-one receptors and anti-gross cystic disease fluid protein 15 (BRST-2) fail to distinguish metastatic breast carcinoma from eccrine neoplasms. Mod Pathol 1995, 8(9):897-901.
8. Su JM, Hsu HK, Chang H, Lin SL, Chang HC, Huang MS, Tseng HH: Expression of estrogen and progesterone receptors in non-small cell lung cancer: Immunohistochemical study. Anticancer Res 1996, 16:3803-3806.
9. Lea OA, Kvinnsland S, Thorsen T: Improved measurement of androgen receptors in human breast cancer. Cancer Res 1989, 49:7162-7167.
10. Ilene B, Bayer-Garner, Smoller Bruce: Androgen Receptors: A marker to increase sensitivity for identifying breast cancer in skin metastasis of unknown primary site. Mod Pathol 2000, 13(2):119-122.
11. Miller WR, Telford J, Dixon JM, Hawkins RA: Androgen receptor activity in human breast cancer and its relationship with estrogen and progesterone receptor activity. Europ J Cancer Clin Oncol 1985, 21:539-542.
12. Knenen-Boumeester V, Van der Kwast Th, van Putten WLJ, Claassen C, van Ooijen B, Henzen-Logmans SC: Immunohistochemical determination of androgen receptors in female breast cancer. Int J Cancer 1992, 52:581-584.
13. Isola JJ: Immunohistochemical demonstration of androgen receptor in breast cancer and its relationship to other prognostic factors. J Pathol 1995, 170:31-35.
14. Hall RE, Aspinall JO, Horsfall DJ, Birrell SN, Bentel JM, Sutherland RL, Tilley WD: Expression of the androgen receptor and an androgen-responsive protein, apolipoprotein D, in human breast cancer. Br J Cancer 1996, 74:1175-1180.
15. Liao S: Cellular receptors and mechanism of action of steroid hormone. Int Rev Cytol 1975, 41:87.
16. Ruizeveld de Winter JA, Trapman J, Vermey M, Mulder E, Zegers ND, van der Kwast TH: Androgen receptor expression in human tissues: an immunohistochemical study. J Histochem Cytochem 1991, 39:927-936.
17. Iwamura M, Abrahamsson PA, Benning CM, Cockett ATK, di Sant'agnese PA: Androgen receptor immunostaining and its tissue distribution in formalin-fixed, paraffin-embedded sections after microwave treatment. J Histochem Cytochem 1994, 42:783-788.
18. Chodak GW, Kranc DM, Puy LA, Takeda H, Kathryn J, Chang C: Nuclear localization of androgen receptor in heterogeneous samples of normal, hyperplastic and neoplastic human prostate. J Urol 1992, 147:798.
19. Magi-Galluzzi C, Xu X, Hlatky L, Hahnfeldt P, Kaplan I, Hsiao Pw, Chang C, Loda M: Heterogeneity of androgen receptor content in advanced prostate cancer. Mod Pothol 1997, 10:839-845.
20. Takeda H, Akakura K, Masai M, Akimoto S, Yatani R, Shimazaki J: Androgen receptor content of prostate carcinoma cells estimated by immunohistochemistry is related to prognosis of patients with stage D2 prostate carcinoma. Cancer 1996, 77:934-940.
21. Pertschuk LP, Macchia RJ, Feldman JG, Brady KA, Levine M, Kim DS, Eisenberg KB, Rainford E, Prins GS, Greene GL: Immunocytochemical assay for androgen receptors in prostate cancer: a prospective study of 63 cases with long-term follow-up. Ann Surg Oncol 1994, 1:495-503.
22. Chadha S, Rao BR, Slotman BJ, van Vroonhoven CCJ, van der Kwast ThH: An immunohistochemical evaluation of androgen and progesterone receptors in ovarian tumors. Hum Pathol 1993, 24:90-95.
23. Kuhnel R, de Graaff J, Rao BR, Stock JG: Androgen receptor predominance in human ovarian carcinoma. J Steroid Biochem 1987, 26:393-397.
24. Horie K, Takakura K, Imai K, Liao S, Mori T: Immunohistochemical localization of androgen receptor in the human endometrium, decidua, placenta and pathological conditions of the endometrium. Hum reproduct 1992, 7:1461.
25. Kapadia SB, Barnes L: Expression of androgen receptor, gross cystic disease fluid protein, and CD44 in salivary duct carcinoma. Mod Patbol 1998, 11:1033-1038.
26. Fan CY, Wang J, Barnes L: Expression of androgen receptor and prostatic specific markers in salivary duct carcinoma. Am J Surg Pothol 2000, 24:579-586.
27. Hwang HC, Mills SE, Patterson K, Gown AM: Expression of androgen receptors in nasopharyngeal angiofibroma: An immunohistochemical study of 24 cases. Mod Pothol 1998, 11:1122-1126.
28. Cohen C, Lawson D, DeRose PB: Sex and androgenic steroid receptor expression in hepatic adenomas. Hum Pathol 1998, 29:1428-1432.
29. Nasser SM, Faquin WC, Dayal Y: Expression of androgen, estrogen, and progesterone receptors in salivary gland tumors. Frequent expression of androgen receptor in a subset of malignant salivary gland tumors. Am J Clin Pathol 2003, 119:801-6.
30. Agoff SN, Swanson PE, Linden H, Hawes SE, Lawton TJ: Androgen receptor expression in estrogen receptor-negative breast cancer. Immunohistochemical, clinical, and prognostic associations. Am J Clin Pathol 2003, 120:725-31.